RNA-binding protein PCBP2 regulates pancreatic β cell function and adaptation to glucose
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci172436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Matthew W Haemmerle und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Diabetes, Obesity, and Metabolism and Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelph…. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Insulin-Secreting Cells, Glucose, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Glucose plays a key role in shaping pancreatic β cell function. Thus, deciphering the mechanisms by which this nutrient stimulates β cells holds therapeutic promise for combating β cell failure in type 2 diabetes (T2D). β Cells respond to hyperglycemia in part by rewiring their mRNA metabolism, yet the mechanisms governing these changes remain poorly understood. Here, we identify a requirement for the RNA-binding protein PCBP2 in maintaining β cell function basally and during sustained hyperglycemic challenge. PCBP2 was induced in primary mouse islets incubated with elevated glucose and was required to adapt insulin secretion. Transcriptomic analysis of primary Pcbp2- deficient β cells revealed impacts on basal and glucose-regulated mRNAs encoding core components of the insulin secretory pathway. Accordingly, Pcbp2- deficient β cells exhibited defects in calcium flux, insulin granule ultrastructure and exocytosis, and the amplification pathway of insulin secretion. Further, PCBP2 was induced by glucose in primary human islets, was downregulated in islets from T2D donors, and impacted genes commonly altered in islets from donors with T2D and linked to single-nucleotide polymorphisms associated with T2D. Thus, these findings establish a paradigm for PCBP2 in governing basal and glucose-adaptive gene programs critical for shaping the functional state of β cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Diabetes, Obesity, and Metabolism and Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
- Department of Pediatrics and.
- Department of Cell & Developmental Biology, and.
- Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Division of Gastroenterology, Hepatology and Nutrition Division, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Förderung
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Haemmerle, M. W., Scota, A. V., Khosravifar, M., Varney, M. J., Sen, S., Good, A. L., Yang, X., Wells, K. L., Sussel, L., Rozo, A. V., Doliba, N. M., Ghanem, L. R., & Stoffers, D. A. (2024). RNA-binding protein PCBP2 regulates pancreatic β cell function and adaptation to glucose. Journal of Clinical Investigation. https://doi.org/10.1172/jci172436
Vancouver
Haemmerle MW, Scota AV, Khosravifar M, Varney MJ, Sen S, Good AL, et al. RNA-binding protein PCBP2 regulates pancreatic β cell function and adaptation to glucose. Journal of Clinical Investigation. 2024. doi:10.1172/jci172436
BibTeX
@article{Haemmerle2024,
author = {Haemmerle, Matthew W and Scota, Andrea V and Khosravifar, Mina and Varney, Matthew J and Sen, Sabyasachi and Good, Austin L and Yang, Xiaodun and Wells, Kristen L and Sussel, Lori and Rozo, Andrea V and Doliba, Nicolai M and Ghanem, Louis R and Stoffers, Doris A},
title = {RNA-binding protein PCBP2 regulates pancreatic β cell function and adaptation to glucose},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci172436}
}
EUVIMED